ClinicalTrials.govpublic full text
Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer
prostate cancer, rad001, mtor inhibition, docetaxel, bevacizumab, adenocarcinoma of the prostate, recurrent prostate cancer, stage iv prostate cancer, metastatic, androgen independent prostate cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805694
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.